Taciani De Almeida Magalhaes, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ependymoma | 4 | 2023 | 325 | 2.500 |
Why?
|
| Supratentorial Neoplasms | 3 | 2023 | 162 | 2.110 |
Why?
|
| Transcription Factor RelA | 3 | 2023 | 285 | 1.000 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2017 | 54 | 0.630 |
Why?
|
| Maternal Deprivation | 1 | 2017 | 47 | 0.630 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2017 | 93 | 0.610 |
Why?
|
| Corticosterone | 1 | 2017 | 311 | 0.600 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 609 | 0.560 |
Why?
|
| Receptors, Notch | 1 | 2019 | 750 | 0.500 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1379 | 0.390 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1421 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2935 | 0.350 |
Why?
|
| Hedgehog Proteins | 2 | 2023 | 777 | 0.300 |
Why?
|
| Brazil | 2 | 2021 | 1222 | 0.280 |
Why?
|
| Glioblastoma | 1 | 2020 | 3339 | 0.260 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 3909 | 0.260 |
Why?
|
| Cerebellar Neoplasms | 2 | 2019 | 588 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5458 | 0.240 |
Why?
|
| Medulloblastoma | 2 | 2019 | 702 | 0.230 |
Why?
|
| Coronavirus OC43, Human | 1 | 2023 | 19 | 0.230 |
Why?
|
| Coronavirus 229E, Human | 1 | 2023 | 16 | 0.230 |
Why?
|
| Cilia | 2 | 2023 | 464 | 0.210 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 94 | 0.170 |
Why?
|
| Protein Array Analysis | 1 | 2019 | 412 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13563 | 0.150 |
Why?
|
| Multigene Family | 1 | 2020 | 1116 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2019 | 513 | 0.140 |
Why?
|
| Pituitary-Adrenal System | 1 | 2017 | 536 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1076 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1761 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2017 | 685 | 0.120 |
Why?
|
| ROC Curve | 1 | 2021 | 3491 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9375 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 1589 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3575 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1796 | 0.100 |
Why?
|
| Ethanol | 1 | 2017 | 1293 | 0.100 |
Why?
|
| Reward | 1 | 2017 | 924 | 0.100 |
Why?
|
| Disease Management | 1 | 2021 | 2442 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4234 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4865 | 0.090 |
Why?
|
| Computational Biology | 1 | 2021 | 3522 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2759 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2946 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8453 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11486 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 10926 | 0.070 |
Why?
|
| Child | 3 | 2021 | 75163 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 71 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19620 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2019 | 40429 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7914 | 0.050 |
Why?
|
| Humans | 8 | 2023 | 725001 | 0.050 |
Why?
|
| Holoprosencephaly | 1 | 2021 | 21 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13759 | 0.050 |
Why?
|
| Biocatalysis | 1 | 2021 | 169 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2021 | 23445 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 410 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2019 | 12081 | 0.040 |
Why?
|
| Animals | 3 | 2021 | 168735 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 39883 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 29645 | 0.040 |
Why?
|
| Male | 4 | 2021 | 346964 | 0.030 |
Why?
|
| Female | 4 | 2021 | 375303 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 80318 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1668 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3284 | 0.030 |
Why?
|
| Cholesterol | 1 | 2021 | 2868 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 3026 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6881 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6527 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6158 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 4314 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12795 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9667 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 16262 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16634 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 28718 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 38720 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 34331 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 55791 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 84411 | 0.010 |
Why?
|